Pancreatic Metastasis Detected by F-18 FDG PET/CT in a Patient With Breast Cancer

Pancreatic involvement by metastasis from other primaries is rare and accounts for approximately 2% to 4% of pancreatic tumors. In this article, we describe FDG-avid pancreatic involvement in a patient with diagnosis of breast cancer. We conclude that FDG PET can be a convenient noninvasive method o...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 2011-06, Vol.36 (6), p.479-480
Main Authors: Lam, Winnie Wing-Chuen, Loke, Kelvin Siu-Hoong, Loi, Hoi Yin, Padhy, Ajit Kumar
Format: Article
Language:English
Subjects:
Adult
Breast Neoplasms - pathology
Female
Fluorodeoxyglucose F18
Humans
Pancreatic Neoplasms - diagnosis
Pancreatic Neoplasms - pathology
Pancreatic Neoplasms - physiopathology
Pancreatic Neoplasms - secondary
Positron-Emission Tomography
Tomography, X-Ray Computed
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pancreatic involvement by metastasis from other primaries is rare and accounts for approximately 2% to 4% of pancreatic tumors. In this article, we describe FDG-avid pancreatic involvement in a patient with diagnosis of breast cancer. We conclude that FDG PET can be a convenient noninvasive method of early detection of recurrence and in monitoring metastatic disease during follow-up in such patients. A positive FDG PET warrants histopathologic correlation for appropriate treatment.
ISSN:0363-9762
1536-0229
DOI:10.1097/RLU.0b013e31820adf47